
Radiant Dx provides multi-omics data platforms that help researchers understand how mutations influence disease and treatment. Powered by Claritas technology, the platform maps tissue-level interactions at cellular resolution and integrates DNA, RNA, protein, epigenetics, and functional data. It is a B2B platform used by research labs, biotechs, and pharmaceutical companies. The solution combines AI-driven predictions and organoid-based approaches for precision cancer diagnostics and drug discovery. This approach scales to large datasets and aims to accelerate breakthroughs in oncology and beyond.

Radiant Dx provides multi-omics data platforms that help researchers understand how mutations influence disease and treatment. Powered by Claritas technology, the platform maps tissue-level interactions at cellular resolution and integrates DNA, RNA, protein, epigenetics, and functional data. It is a B2B platform used by research labs, biotechs, and pharmaceutical companies. The solution combines AI-driven predictions and organoid-based approaches for precision cancer diagnostics and drug discovery. This approach scales to large datasets and aims to accelerate breakthroughs in oncology and beyond.